The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 25, 2020

Filed:

Jul. 23, 2018
Applicant:

Sri International, Menlo Park, CA (US);

Inventors:

David E. Cooper, Menlo Park, CA (US);

Robert Balog, Menlo Park, CA (US);

Polly Chang, Menlo Park, CA (US);

Thomas A. Shaler, Menlo Park, CA (US);

Hua Lin, Menlo Park, CA (US);

Annalisa D'Andrea, Menlo Park, CA (US);

Travis Harrison, Menlo Park, CA (US);

Roger H. Schmidt, Menlo Park, CA (US);

Christina Swanson, Menlo Park, CA (US);

Estevan Mendoza, Menlo Park, CA (US);

Mark Steele, Menlo Park, CA (US);

Pablo E. Garcia, Menlo Park, CA (US);

Assignee:

SRI INTERNATIONAL, Menlo Park, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G01N 33/53 (2006.01); G01N 33/68 (2006.01); G01N 33/49 (2006.01); G01N 33/558 (2006.01);
U.S. Cl.
CPC ...
G01N 33/5302 (2013.01); G01N 33/491 (2013.01); G01N 33/558 (2013.01); G01N 33/6893 (2013.01); G01N 2800/40 (2013.01);
Abstract

Materials, systems and methods are provided for qualitative assessment of exposure of a person to ionizing radiation by measuring amounts of the biomarkers, wherein a change compared with corresponding un-irradiated control reference ranges of the biomarkers, provides the assessment, wherein the biomarkers include (i) alpha-1-Antichymotrypsin (ACT), (ii) Fms-related tyrosine kinase 3 ligand (Flt3L), and (iii) one or more additional proteins.


Find Patent Forward Citations

Loading…